Equity Overview
Price & Market Data
Price: $2.55
Daily Change: -$0.20 / 7.84%
Daily Range: $2.55 - $2.97
Market Cap: $103,600,120
Daily Volume: 70,826
Performance Metrics
1 Week: -6.47%
1 Month: -2.26%
3 Months: 8.33%
6 Months: -48.41%
1 Year: -66.28%
YTD: -68.06%
Company Details
Employees: 64
Sector: Health services
Industry: Medical/Nursing services
Country:
Details
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.